CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-07 | Brannan Stephen K. Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-11-07 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-11-07 | Bailey Gregory Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-11-07 | WILSON KAREN J Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-11-05 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +3,398 | $0.06 | $204 | 3,398 |
| 2025-11-05 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −3,398 | $4.24 | $14K | 0 |
| 2025-11-05 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,398 | 397,686 | ||
| 2025-11-04 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +3,102 | $0.06 | $186 | 3,102 |
| 2025-11-04 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −3,102 | $4.40 | $14K | 0 |
| 2025-11-04 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,102 | 401,084 | ||
| 2025-10-28 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +5,551 | $0.06 | $333 | 5,551 |
| 2025-10-28 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −5,551 | $4.96 | $28K | 0 |
| 2025-10-28 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,551 | 404,186 | ||
| 2025-10-27 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +949 | $0.06 | $57 | 949 |
| 2025-10-27 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −949 | $5.19 | $5K | 0 |
| 2025-10-27 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −949 | 409,737 | ||
| 2025-10-20 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +6,500 | $0.06 | $390 | 6,500 |
| 2025-10-20 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −6,500 | $4.97 | $32K | 0 |
| 2025-10-20 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,500 | 410,686 | ||
| 2025-10-13 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +4,326 | $0.06 | $260 | 4,326 |
Page 6 of 12 · 223 trades